Skip to main content

Table 1 Baseline clinical and serological characteristics of patients with RA

From: Reduction of autophagy and increase in apoptosis correlates with a favorable clinical outcome in patients with rheumatoid arthritis treated with anti-TNF drugs

Characteristic Value
Demographic parameters
 Sex, F/M 23/2
 Age, mean (SD), years 59 (12.6)
 Disease duration, mean (SD), years 6.3 (8.8)
Laboratory parameters
 ESR, mean (mm/h) (SD) 17.6 (9.3)
 CRP, mean (mg/dL) (SD) 0.68 (0.65)
 RF positivity, n (%) 19 (76)
 ACPA positivity, n (%) 18 (72)
Disease activity
 TJ n, mean (SD) 5.8 (5.4)
 SJ n, mean (SD) 2.6 (2.4)
 CDAI, mean (SD) 19.3 (10.8)
 DAS28, mean (SD) 4.2 (1.6)
Therapy
 Etanercept, n (%) 20 (80)
 Adalimumab, n (%) 5 (20)
 Concurrent MTX, n (%) 13 (52)
  1. SD standard deviation, ESR Erythrocyte Sedimentation Rate, CRP C-Reactive Protein, RF Rheumatoid Factor, ACPA anti-citrullinated peptide antibodies, TJ Tender joints, SJ swollen joints, CDAI Clinical Disease Activity Index, DAS28 Disease Activity Score on 28 joints, csDMARDs conventional synthetic disease-modifying antirheumatic drugs